CXO up +5.06% percent right now. $CXO High is at 118.78 and

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
CXO up +5.06% percent right now. $CXO High is at 118.78 and the Low 112.05 with current volume of 3,019,100.

Recent News posted below.

CXO Concho Resources Inc Recent Headline News

Concho Resources Inc. Announces Participation in Upcoming Conferences
Business Wire - Fri Nov 07, 4:08PM CST
Concho Resources Inc. (NYSE: CXO) (the "Company" or "Concho" today announced its upcoming participation at the Executive Oil Conference on Tuesday, November 11th at 10:30 AM CST, the Bank of America Merrill Lynch 2014 Global Energy Conference on Thursday, November 13th at 9:00 AM EST, the Ladenburg One-on-One E&P Conference on Wednesday, November 19th, the Bank of America Merrill Lynch 2014 Leveraged Finance Conference on Tuesday, December 2nd at 9:30 AM EST, and the Capital One Securities, Inc. 9th Annual Energy Conference on Thursday, December 11th at 11:40 AM CST.
CXO: 117.88 (+5.68)

Concho Resources (CXO) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Thu Nov 06, 6:58PM CST
The following Concho Resources (CXO) conference call took place on November 6, 2014, 09:30 AM ET. This is a transcript of that earnings call:
CXO: 117.88 (+5.68)

Concho Resources Inc. Announces Resignation of A. Wellford Tabor from Its Board of Directors
Business Wire - Thu Nov 06, 5:08PM CST
Concho Resources Inc. (NYSE: CXO) (the "Company" or "Concho" today announced that A. Wellford Tabor has resigned from the Board of Directors and all its committees.
CXO: 117.88 (+5.68)

3 Basic Materials Stocks On The Rise
at The Street - Thu Nov 06, 11:05AM CST
TheStreet highlights 3 stocks pushing the basic materials sector higher today.
CXO: 117.88 (+5.68), MPC: 94.08 (+0.95), KMP: 94.73 (+0.23)

Third Quarter 2014 Results, Market Activity, and Stock Rating - Research Reports on Emerge Energy, Cimarex Energy, Suncor, Range and Concho
PR Newswire - Thu Nov 06, 8:05AM CST
Today, Analysts Review released its research reports regarding Emerge Energy Services LP (NYSE: EMES), Cimarex Energy Co. (NYSE: XEC), Suncor Energy Inc. (NYSE: SU), Range Resources Corporation (NYSE: RRC) and Concho Resources, Inc. (NYSE: CXO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7757-100free.
CXO: 117.88 (+5.68), SU: 34.57 (+0.95), EMES: 83.24 (+5.42), XEC: 118.34 (+3.54), RRC: 73.09 (+0.29)

Concho Resources tops 3Q profit forecasts
Automated Insights - Wed Nov 05, 4:45PM CST
MIDLAND, Texas (AP) _ Concho Resources Inc. (CXO) on Wednesday reported third-quarter earnings of $305.2 million.
CXO: 117.88 (+5.68)

Concho Resources Inc. Reports Third Quarter 2014 Results and Provides 2015 Outlook
Business Wire - Wed Nov 05, 4:30PM CST
Concho Resources Inc. (NYSE: CXO) (the "Company" or "Concho" today reported results for the third quarter of 2014 and provided an outlook for 2015.
CXO: 117.88 (+5.68)

After Yesterday's Decline of 3.49%, Concho Resources Offers Investors Better Value
Comtex SmarTrend(R) - Tue Nov 04, 5:24PM CST
Concho Resources (NYSE:CXO) traded in a range yesterday that spanned from a low of $102.05 to a high of $104.89. Yesterday, the shares fell 3.5%, which took the trading range below the 3-day low of $103.80 on volume of 1.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CXO: 117.88 (+5.68)

SmarTrend Watching for Potential Rebound in Shares of Concho Resources After 3.49% Loss
Comtex SmarTrend(R) - Tue Nov 04, 5:24PM CST
Concho Resources (NYSE:CXO) traded in a range yesterday that spanned from a low of $102.05 to a high of $104.89. Yesterday, the shares fell 3.5%, which took the trading range below the 3-day low of $103.80 on volume of 1.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CXO: 117.88 (+5.68)

Concho Resources (CXO) Downgraded From Buy to Hold
at The Street - Mon Nov 03, 8:29AM CST
Concho Resources (CXO) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+.
CXO: 117.88 (+5.68)

Energy Stocks Technical Coverage - Cimarex Energy, Midstates Petroleum, Parsley Energy, Concho Resources, and BreitBurn Energy Partners
PR Newswire - Fri Oct 31, 7:30AM CDT
Investor-Edge has initiated coverage on the following equities: Cimarex Energy Company (NYSE: XEC), Midstates Petroleum Company Inc. (NYSE: MPO), Parsley Energy Inc. (NYSE: PE), Concho Resources Inc. (NYSE: CXO), and BreitBurn Energy Partners L.P. (NASDAQ: BBEP). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Thursday, October 30, 2014, the NASDAQ Composite ended at 4,566.14, up 0.37%, the Dow Jones Industrial Average advanced 1.30%, to finish the day at 17,195.42, and the S&P 500 closed at 1,994.65, up 0.62%. The gains were broad based as nine out of ten sectors ended the session in positive. The S&P 500 Energy Sector Index ended the day at 628.50, down 0.31%, while the index has advanced 2.12% in the previous three trading sessions. Register for your complimentary reports on these five stocks at:
CXO: 117.88 (+5.68), XEC: 118.34 (+3.54), BBEP: 16.61 (-0.09), PE: 16.42 (+0.60), MPO: 3.11 (+0.07)

Look for Shares of Concho Resources to Potentially Rebound after Yesterday's 3.24% Sell Off
Comtex SmarTrend(R) - Mon Oct 27, 5:05PM CDT
Concho Resources (NYSE:CXO) traded in a range yesterday that spanned from a low of $102.18 to a high of $106.25. Yesterday, the shares fell 3.2%, which took the trading range below the 3-day low of $106.11 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CXO: 117.88 (+5.68)

Watch for Concho Resources to Potentially Rebound After Falling 3.24% Yesterday
Comtex SmarTrend(R) - Mon Oct 27, 5:04PM CDT
Concho Resources (NYSE:CXO) traded in a range yesterday that spanned from a low of $102.18 to a high of $106.25. Yesterday, the shares fell 3.2%, which took the trading range below the 3-day low of $106.11 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CXO: 117.88 (+5.68)

Concho Resources (CXO) Stock: Weak On High Volume Today
at The Street - Mon Oct 27, 9:00AM CDT
Trade-Ideas LLC identified Concho Resources (CXO) as a weak on high relative volume candidate
CXO: 117.88 (+5.68)

Downgrade Alert for Concho Resources (CXO)
Comtex SmarTrend(R) - Mon Oct 27, 7:05AM CDT
Concho Resources (NYSE:CXO) was downgraded from Buy to Hold at Stifel today. The stock closed yesterday at $108.99 on volume of 1.2 million shares, below average daily volume of 1.6 million. Concho Resources Inc. acquires, develops and explores for oil and natural gas properties in the Permian Basin area of Southeast New Mexico and West Texas.
CXO: 117.88 (+5.68)

Concho Resources Down 26.0% Since SmarTrend Downtrend Call (CXO)
Comtex SmarTrend(R) - Tue Oct 14, 4:51PM CDT
SmarTrend identified a Downtrend for Concho Resources (NYSE:CXO) on September 8th, 2014 at $131.25. In approximately 1 month, Concho Resources has returned 25.96% as of today's recent price of $97.18.
CXO: 117.88 (+5.68)

After Yesterday's Decline of 7.18%, Concho Resources Offers Investors Better Value
Comtex SmarTrend(R) - Mon Oct 13, 4:37PM CDT
Concho Resources (NYSE:CXO) traded in a range yesterday that spanned from a low of $97.70 to a high of $107.03. Yesterday, the shares fell 7.2%, which took the trading range below the 3-day low of $104.78 on volume of 3.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CXO: 117.88 (+5.68)

SmarTrend Watching for Potential Rebound in Shares of Concho Resources After 7.18% Loss
Comtex SmarTrend(R) - Mon Oct 13, 4:37PM CDT
Concho Resources (NYSE:CXO) traded in a range yesterday that spanned from a low of $97.70 to a high of $107.03. Yesterday, the shares fell 7.2%, which took the trading range below the 3-day low of $104.78 on volume of 3.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CXO: 117.88 (+5.68)

Why Lower Oil Prices Are Great for Consumers, Terrible for the Stock Market
at The Street - Mon Oct 13, 12:49PM CDT
Lower oil prices are great for users of oil but bad for producers. Unfortunately, in the past five years, the U.S. has become a major producer again.
CXO: 117.88 (+5.68), WLL: 59.44 (+1.49), PXD: 176.70 (+1.87), HAL: 53.86 (+0.69), EOG: 99.55 (+0.58), APA: 76.52 (+1.08), SLB: 98.73 (+1.75), BHI: 52.30 (+0.81)

Major Indexes Turn Higher; F5 Networks, Baidu Rally
at Investor's Business Daily - Mon Oct 13, 12:31PM CDT
Stocks turned higher in volatile early-afternoon trading after a rocky start. Techs, which were down the hardest Friday, led the rebound. The Nasdaq gained 0.5%, bumping up against its 200-day line breached Friday. It had been down 1.3% at Monday's...
CXO: 117.88 (+5.68), GPRO: 79.06 (+0.30), BIDU: 236.54 (-0.36), FFIV: 126.66 (+1.45), FANG: 69.49 (+3.67), PHX: 21.24 (+0.69)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 225

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 308

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 412

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 106

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 130

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 288

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 131

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 127

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Kinetic Seas Incorporated Secures First Customer Success

Updated Category News Views 56

Kinetic Seas Incorporated Secures First Customer and Financial Growth Kinetic Seas Incorporated (OTC: ECGR) is excited to announce the signing of its first customer, along with impressive revenue results for the second quarter. This milestone marks a significant step forward as the company pursues its goals in the artificial intelligence sector. Second Quarter Revenue...

Continue Reading
Webinar Guide for Veterans to Maximize Benefits Offered by CCK Law

Updated Category News Views 134

Helping Veterans Discover VA Benefits with a Free Webinar Chisholm Chisholm & Kilpatrick LTD (CCK Law), a preeminent veterans disability law firm, is excited to introduce a free, on-demand webinar aimed at assisting veterans in uncovering valuable VA benefits that many may be unaware of. Insights from the Experts The webinar, dubbed "Biggest Benefits Veterans Overlook,"...

Continue Reading
Tech Market Shifts: Navigating Opportunities and Challenges Ahead

Updated Category News Views 161

Understanding Recent Market Dynamics In recent weeks, global markets have been experiencing heightened volatility, particularly in the technology sector. With various significant events unfolding—including new political leadership in Japan and shifts in economic data—investors are carefully analyzing these developments to navigate potential risks and opportunities....

Continue Reading
Michael Beland Joins Advance Auto Parts as Chief Accounting Officer

Updated Category News Views 720

Welcome Michael Beland to Advance Auto Parts Advance Auto Parts, Inc. (NYSE: AAP), known for its significant role in the automotive aftermarket, recently made an important announcement regarding its executive leadership. The company has appointed Michael Beland as the new senior vice president, controller, and chief accounting officer, marking a pivotal addition to their...

Continue Reading
Recall Movement Against Governor Newsom Gains Momentum

Updated Category News Views 276

Recall Movement Gains Traction in California In an unprecedented move, SavingCalifornia.vote has taken a significant step to initiate a recall against Governor Gavin Newsom. This initiative marks a pivotal moment in California's political landscape. The organization is gathering support and will soon submit the official notice of intent to recall, alongside the necessary...

Continue Reading